EZZ Life Science Holdings Ltd (EZZ) - Total Liabilities

Latest as of December 2025: AU$4.80 Million AUD ≈ $3.39 Million USD

Based on the latest financial reports, EZZ Life Science Holdings Ltd (EZZ) has total liabilities worth AU$4.80 Million AUD (≈ $3.39 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EZZ Life Science Holdings Ltd (EZZ) asset resilience to evaluate the company's liquid asset resilience ratio.

EZZ Life Science Holdings Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how EZZ Life Science Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see EZZ total asset value.

EZZ Life Science Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of EZZ Life Science Holdings Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Klimator AB ST:KLIMAT	Sweden	Skr16.89 Million
Vision Sigma TA:VISN	Israel	ILA284.59 Million
City Steel Public Company Limited BK:CITY	Thailand	฿19.28 Million
Volex Plc LSE:VLX	UK	GBX586.67 Million
Malaysian Genomics Resource KLSE:0155	Malaysia	RM3.09 Million
Magnum Mining and Exploration Ltd AU:MGU	Australia	AU$1.11 Million
Quoin Pharmaceuticals Ltd DRC NASDAQ:QNRX	USA	$8.04 Million
Sampann Utpadan India Limited NSE:SAMPANN	India	Rs1.08 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down EZZ Life Science Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of EZZ Life Science Holdings Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EZZ Life Science Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EZZ Life Science Holdings Ltd (2017–2024)

The table below shows the annual total liabilities of EZZ Life Science Holdings Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$5.87 Million ≈ $4.15 Million	+38.83%
2023-12-31	AU$4.23 Million ≈ $2.99 Million	+38.28%
2022-12-31	AU$3.06 Million ≈ $2.16 Million	+6.27%
2021-12-31	AU$2.88 Million ≈ $2.04 Million	+49.05%
2020-12-31	AU$1.93 Million ≈ $1.37 Million	-48.86%
2019-12-31	AU$3.78 Million ≈ $2.67 Million	+80.61%
2018-12-31	AU$2.09 Million ≈ $1.48 Million	--
2017-12-31	AU$0.00 ≈ $0.00	--

About EZZ Life Science Holdings Ltd

AU:EZZ Australia Biotechnology

Market Cap

$13.65 Million

AU$19.29 Million AUD

Market Cap Rank

#26355 Global

#1191 in Australia

Share Price

AU$0.41

Change (1 day)

-1.20%

52-Week Range

AU$0.37 - AU$3.32

All Time High

AU$4.93